For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Anticancer, Inc.

USPTO Granted Patents = 66

% Expired Patents = 31.8

CIPO Patents = 1

EPO Patents = 15

Trademarks = 3

Forward Citations = 683

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Yuying Tan (31 out of 31 patents)

Mingxu Xu (16 out of 16 patents)

Lingna Li (15 out of 16 patents)

4. Qinghong Han (10 out of 12 patents)

5. Valeryi Lishko (8 out of 8 patents)

6. Meng Yang (7 out of 8 patents)

7. Shukuan Li (6 out of 6 patents)

8. Robert M Hoffman (5 out of 7 patents)

9. Shigeo Yagi (5 out of 5 patents)

10. Li Tang (5 out of 5 patents)

11. Takashi Chishima (5 out of 5 patents)

12. Ming Zhao (4 out of 4 patents)

13. Zhijian Yang (4 out of 4 patents)

14. Xinghua Sun (4 out of 4 patents)

15. Eugene Baranov (4 out of 8 patents)

Core Competencies:

Cancer Selective Auxotrophs

Methioninase Gene Therapy

Tumor Models

Selenium Pro-Drugs

PEG Conjugation

Hair Follicle Stem Cells

Metastasis Models

Biological Fluid Assays

Histoculturing Methods

Protein Conjugation

Tumor Treatment

Alopecia Treatment

66 patents: Sort by Forward Citations

1. 12023370 - Composition for the treatment of COVID-19 infection, and a method of treatment (2024-07-02),

2. 11871731 - Transplantation method to increase the establishment rate of human tumors in immunodeficient mice (2024-01-16),

3. 11001826 - Orally administered composition to lower serum methionine levels and method of use (2021-05-11),

4. 9539290 - Individualized bacterial treatment of pancreatic cancer (2017-01-10),

5. 9464312 - Schiff-base conjugate of N, N-dibutyl-P-phenylenediamine with pyridoxal 5'-phosphate for improved homocysteine assays using pyridoxal 5′-phosphate-dependent enzymes (2016-10-11),

6. 8822194 - Cancer selective auxotrophs (2014-09-02),

7. 8481318 - Nestin-expressing hair follicle stem cells (2013-07-09),

8. 8465734 - Methods for increasing protein polyethylene glycol (PEG) conjugation (2013-06-18),

9. 8217222 - Methods for identifying markers for early-stage human cancer, cancer progression and recurrence (2012-07-10),

10. 8148600 - Immunocompromised rodents as dual color tumor models (2012-04-03),

11. 7799549 - Methods for increasing protein polyethylene glycol (PEG) conjugation (2010-09-21),

12. 7666675 - Nestin-expressing hair follicle stem cells (2010-02-23),

13. 7625550 - Enhanced resolution of tumor metastasis using a skin flap model (2009-12-01),

14. 7556825 - Method for promoting hair growth (2009-07-07),

15. 7329516 - Methods for increasing protein polyethylene glycol (PEG) conjugation (2008-02-12),

Anticancer, Inc. is a biotechnology company based in San Diego, California, specializing in innovative cancer treatment solutions. The company focuses on developing advanced therapies utilizing cancer selective auxotrophs and methioninase gene therapy, alongside creating sophisticated tumor models and metastasis models for research purposes. Their expertise extends to the formulation of selenium pro-drugs and PEG conjugation techniques, as well as exploring the potential of hair follicle stem cells and biological fluid assays in cancer treatment and diagnostics.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Anticancer, Inc.

66 Patents

#95 in San Diego, CA

#1,287 in California

#5,520 in US

#11,150 in the World

San Diego, CA, United States of America

Anticancer, Inc.

Forward Citations = 683

40 inventors:

Yuying Tan (31 out of 31 patents)

Mingxu Xu (16 out of 16 patents)

Lingna Li (15 out of 16 patents)

4. Qinghong Han (10 out of 12 patents)

5. Valeryi Lishko (8 out of 8 patents)

Please report any incorrect information to [email protected]

Loading…